Sunday, June 13, 2021

J&J

US J&J Covid vaccine pause continues after experts defer vote

Most feel that further study is necessary given the highly serious nature of the clots, which can have devastating neurological consequences even when they do not kill.

Johnson & Johnson vaccine ‘highly effective’ against severe Covid-19

In large clinical trials, the vaccine efficacy against severe disease was 85.9% in the US, 81.7% in South Africa, and 87.6% in Brazil.

Other News